Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from New Tracers, New Agents and New Stressors

  • You have access
    The PPARα activator fenofibrate fails to alter myocardial metabolism in healthy individuals despite marked peripheral effects
    Pablo Soto, Pilar Herrero, Jeffrey Baumstark, Faye Rao, Kenneth Schechtman and Robert Gropler
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 419;
  • You have access
    Multitracer PET characterization of the biology of the cardiac sympathetic nervous system in healthy volunteers
    Riikka Lautamaki, Daniel Holt, Hayden Ravert, Jennifer Merrill, John Hilton, Robert F Dannals and Frank M Bengel
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 422;
  • You have access
    A phase I study evaluating dosimetry and myocardial pharmacokinetic behavior of BFPET, a new F-18 labeled tracer for myocardial perfusion imaging
    David Elmaleh, Arash Kardan, Sandra Barrow, Steven Dragotakes, John Correia, Steven Weise, Boyan Goumnerov, Ljiljana Kundakovic, Henry Gewirtz and Alan Fischman
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 420;
  • You have access
    Tc-99m MIBI defect in 3-hr delayed imaging corresponds with I-123 BMIPP defect in site and size in the patients with TAKOTSUBO cardiomyopathy.
    Keisuke Kiso, Yoritaka Otsuka and Yoshio Ishida
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 417;
  • You have access
    Decreased myocardial perfusion reserve in patients with ARVC using H215O-PET
    Kambiz Rahbar, Matthias Paul, Peter Kies, Eric Schulze-Bahr, Otmar Schober, Guenster Breithardt, Thomas Wichter and Michael Schaefers
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 421;
  • You have access
    Imaging properties of F-18 labeled myocardial perfusion PET agent, BMS747158: Dosage, acquisition time and scanner type
    James Case, Jamshid Maddahi, Frank Bengel, Timothy Bateman, M Dahlbom and Joel Lazewatsky
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 418;
  • You have access
    Effect of race/ethnic origin on the efficacy and safety of regadenoson versus adenosine in MPI
    Manuel Cerqueira and Frank Papatheofanis
    Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 416;
SNMMI

© 2025 SNMMI

Powered by HighWire